-
Syndrome differentiation and treatment, three-in-one system of TCM remote consultation to assist in the diagnosis and treatment of new coronary cases in Fujian
Time of Update: 2021-10-10
Chinanews At the scene, Li Candong, President of Fujian University of Traditional Chinese Medicine, Lin Haibin, Secretary of the Party Committee of the Affiliated Hospital of Putian University, relevant persons in charge of the Third People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, and experts from Fujian University of Traditional Chinese Medicine, Fujian Traditional Chinese Medicine Anti-epidemic Aid Medical Team, and Affiliated Hospital of Putian University Attend the consultation .
-
New type of decoction pieces or a big outbreak, the equipment industry will have a lot to do
Time of Update: 2021-10-10
The broken-wall decoction pieces break the plant cell wall through modern ultra-fine pulverization technology, and release the effective ingredients of traditional Chinese medicine so that the ingredients can be better absorbed by the human body.
-
Genting Shinya submitted a new drug application for Xerava(TM) for the treatment of complicated intra-abdominal infections in Hong Kong, China
Time of Update: 2021-10-10
HK), a biopharmaceutical company focusing on the development and commercialization of innovative drugs, is committed to satisfying the unsatisfied Asian market Medical needs, today announced that it has submitted a new drug listing application for XeravaTM (Elacycline) for the treatment of complex intra-abdominal infection (cIAI) in adults to the Department of Health of the Hong Kong Special Administrative Region of China .
-
With the rapid development of innovative drugs, investors are increasingly concerned about whether pharmaceutical companies have the ability to "go global"
Time of Update: 2021-10-10
Analysts said that there are more and more products and clinical trials of innovative drugs in China and the United States, which is a general trend .
-
The State Food and Drug Administration issued technical guidelines for clinical trials of new in vitro diagnostic reagents
Time of Update: 2021-10-10
The plan shall make clear provisions on the type of trial design, selection of comparison methods, selection of subjects, evaluation indicators, statistical analysis methods, sample size estimation and quality control requirements, etc.
-
Hengrui counterattacks Yangtze River!
Time of Update: 2021-10-10
Can Hengrui take this advantage to return to its high position?Picture 1: Hengrui's latest product declarationSource: CDE official websiteFigure 2: Changes in the share of dexmedetomidine hydrochloride injection TOP3 companiesSource: Mi Nei. com, China's public medical institutions terminal competition patternDexmedetomidine is an α2 adrenergic receptor agonist, mainly used for tracheal intubation and sedation during mechanical ventilation in patients undergoing general anesthesia .
-
The basic medical insurance for urban and rural residents will be insured from October
Time of Update: 2021-10-10
A reporter from Beijing Youth Daily noted that the "Announcement" made it clear that the time for applying for the basic medical insurance for urban and rural residents in this city in 2022 will be from October 1 to December 30, 2021, and the personal payment standard will be the same as in 2021 .
-
With the continued positive development of the pharmaceutical packaging industry, this type of enterprise has a broad market prospect
Time of Update: 2021-10-10
From the perspective of development trends, China is currently continuously introducing and upgrading pharmaceutical packaging equipment and materials, and the entire industry is showing a brand new situation .
-
Two pharmaceutical companies join forces to enter the drug market over 10 billion yuan
Time of Update: 2021-10-10
Taking the first marketed target PARP inhibitor for synthetic lethal therapy as an example, according to evaluate Pharma’s forecast, only four types (Olaparib, Niraparib, Niraparib, and Rucaparib) approved globally by 2020 will be considered.
-
2 Qilu Class 1 biological drugs are coming!
Time of Update: 2021-10-10
On September 28, CDE's official website showed that Qilu Pharmaceutical's QLF32004 and QLP31907 injections for class 1 biological drug injections have obtained the implied license of clinical trials and are intended to be used for the treatment of advanced malignant solid tumors and B-cell malignant tumors .
-
Will taking antihypertensive drugs be resistant?
Time of Update: 2021-10-10
The blood pressure control of a certain drug is related to the patient's age, compliance, eating habits and other factors .
-
Virus traceability is more than "difficult"!
Time of Update: 2021-10-09
October 1, China Ke Xueyuan Academy of Sciences , Chinese Center for Disease Control of the main Rengao Fu team, Beijing University of Chemical Technology Tong Yi Gang team in the "Lancet" international top Journal issued a document review traceable history at the same time, pointed out that the new crown virus traceability is a " Protracted war" requires time, international resources and cooperation .
-
Nobel Prize in Physiology or Medicine: mRNA technology has a loud voice
Time of Update: 2021-10-09
On September 23, the Nobel Foundation announced that affected by the new crown epidemic, the 2021 Nobel Prize in Physics, Chemistry, Physiology or Medicine, Literary Prize, and Economics Prize winners will continue the same way as last year and be awarded in their respective countries.
-
New study: COVID-19 has shortened life expectancy in many European and American countries
Time of Update: 2021-10-09
A study recently published by Oxford University in the United Kingdom showed that due to the impact of the new crown epidemic, life expectancy at birth in many countries in Europe and the United States will be shortened in 2020, which is the largest drop since World War II.
-
WHO: A total of 231,551,680 confirmed cases of new crowns worldwide
Time of Update: 2021-10-09
WHO: The global cumulative number of confirmed cases of new crown reached 231551680 WHO: The global cumulative number of confirmed cases of new crown reaches 231551680 WHO: The glob
-
Health Commission: 25 new cases were diagnosed on the 28th, including 11 cases in the local area
Time of Update: 2021-10-09
As of 24:00 on September 28, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 949 confirmed cases (including 5 severe cases), 90,521 cured and discharged cases, and 4,636 deaths.
-
European Medicines Agency considers rapid approval of Merck's oral anti-corona drug
Time of Update: 2021-10-09
The European Medicines Agency announced on the 4th that it supports people aged 18 and over to receive a booster shot of Pfizer's new crown vaccine.
-
Three generations of old, middle-aged and youth relay race against the virus to lead the way for students
Time of Update: 2021-10-09
The first batch of Huang Danian-style teachers at Fudan University in China: Three generations of old, middle-aged and youth relay race against the virus to lead the way for students T
-
Major pharmaceutical companies are accelerating their "staking out of the race" in the field of rare disease drugs
Time of Update: 2021-10-09
However, it is worth noting that due to the small number of patients, low market demand, and high R&D costs for drugs for rare diseases, there are few pharmaceutical companies paying attention and R&D; therefore, there are still huge unmet needs, as well as barriers to approval and payment .
-
Guarding the "River of Life": Are your blood vessels healthy?
Time of Update: 2021-10-09
Xinhua News Agency reporter Lin Miaomiao The blood vessels extending in all directions are like rivers.
According to Shu Chang, director of the Vascular Surgery Center of Fuwai Hospital, Chinese Academy of Medical Sciences , the most common, preventable and curable vascular disease is atherosclerosis.
